Sarepta Therapeutics Inc (NAS:SRPT)
$ 114.37 0.05 (0.04%) Market Cap: 10.92 Bil Enterprise Value: 11.12 Bil PE Ratio: 74.27 PB Ratio: 8.94 GF Score: 85/100

Q4 2023 Sarepta Therapeutics Inc Earnings Call Transcript

Feb 28, 2024 / 09:30PM GMT
Release Date Price: $137.5 (-2.85%)
Unidentified Company Representative

(technical difficulty)

These involve risks and uncertainties, many of which are beyond Sarepta's control. Actual results could materially differ from these forward-looking statements, and any such risks can materially and adversely affect the business, the results of operations and trading prices for Sarepta's common stock. For a detailed description of applicable risks and uncertainties, we encourage you to review the company's most recent annual report on Form 10-K filed with the SEC as well as the company's other SEC filings. The company does not undertake any obligation to publicly update its forward-looking statements, including any financial projections provided today based on subsequent events or circumstances. And now I'll turn the call over to our President and CEO, Doug Ingram, who will provide an overview of our recent progress. Doug?

Douglas S. Ingram
Sarepta Therapeutics, Inc. - President, CEO & Director

Thank you, Fran. By the way, everyone, it was France birthday yesterday. So happy birthday Fran and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot